Literature DB >> 9372874

Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin.

G T MacLennan1, G M Farrow, D G Bostwick.   

Abstract

OBJECTIVES: To assess the nature of a series of unusual low-grade mucin-producing tubulocystic renal cancers diagnosed at the Mayo Clinic since 1985.
METHODS: We reviewed the clinical, radiologic, and pathologic features of 13 unusual low-grade renal carcinomas with features most suggestive of collecting duct origin.
RESULTS: In 8 cases, the tumor was discovered incidentally. Presenting symptoms in the other 5 patients were similar to those of typical renal carcinoma. Imaging studies and angiography disclosed solid, cystic, or complex masses that were relatively avascular. Pathologic assessment revealed good circumscription, minimal hemorrhage and/or necrosis, minimal tendency to extend beyond the kidney, tubulocystic architecture, a fibrotic interface with adjacent normal renal parenchyma, low nuclear grade, and minimal mitotic activity. Mucin production was noted in all evaluable cases. All tumors expressed keratins AE1/AE3 and/or Cam 5.2. The tumors showed immunoreactivity to antibodies directed against keratin 34 beta E12 (8 of 13 cases), and Ulex Europeus antigen 1 (6 of 10 cases). Follow-up ranged from 12 to 114 months (mean 62). No metastases occurred in 12 patients. One patient died of metastatic carcinoma morphologically identical to the primary renal neoplasm 46 months after his tumor had been misinterpreted as a benign condition.
CONCLUSIONS: We believe the tumors described in this article may be of collecting duct origin, representing the low-grade end of a spectrum of cancers arising in collecting duct epithelium.

Entities:  

Mesh:

Year:  1997        PMID: 9372874     DOI: 10.1016/S0090-4295(97)00335-X

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  33 in total

Review 1.  Chinese guidelines on the management of renal cell carcinoma (2015 edition).

Authors:  Jun Guo; Jianhui Ma; Yan Sun; Shukui Qin; Dingwei Ye; Fangjian Zhou; Zhisong He; Xinan Sheng; Feng Bi; Dengfeng Cao; Yingxia Chen; Yiran Huang; Houjie Liang; Jun Liang; Jiwei Liu; Wenchao Liu; Yueyin Pan; Yongqian Shu; Xin Song; Weibo Wang; Xiuwen Wang; Xiaoan Wu; Xiaodong Xie; Xin Yao; Shiying Yu; Yanqiao Zhang; Aiping Zhou
Journal:  Ann Transl Med       Date:  2015-11

2.  Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.

Authors:  Maria Pané Foix; Ana Dunatov; Petr Martinek; Enric Condom Mundó; Saul Suster; Maris Sperga; Jose I Lopez; Monika Ulamec; Stela Bulimbasic; Delia Perez Montiel; Reza Alaghehbandan; Kvetoslava Peckova; Krystina Pivovarcikova; Daum Ondrej; Pavla Rotterova; Faruk Skenderi; Kristyna Prochazkova; Martin Dusek; Milan Hora; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2016-09-15       Impact factor: 4.064

Review 3.  Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Authors:  Simon Chowdhury; Marc R Matrana; Christopher Tsang; Bradley Atkinson; Toni K Choueiri; Nizar M Tannir
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

Review 4.  Diagnostic approach to eosinophilic renal neoplasms.

Authors:  Oleksandr N Kryvenko; Merce Jorda; Pedram Argani; Jonathan I Epstein
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

5.  Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.

Authors:  Yasser Ged; Ying-Bei Chen; Andrea Knezevic; Mark T A Donoghue; Maria I Carlo; Chung-Han Lee; Darren R Feldman; Sujata Patil; A Ari Hakimi; Paul Russo; Martin H Voss; Robert J Motzer
Journal:  Clin Genitourin Cancer       Date:  2019-05-02       Impact factor: 2.872

6.  CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review.

Authors:  F Cornelis; D Ambrosetti; L Rocher; L E Derchi; B Renard; P Puech; M Claudon; O Rouvière; S Ferlicot; C Roy; M Yacoub; N Grenier; J C Bernhard
Journal:  Eur Radiol       Date:  2016-06-22       Impact factor: 5.315

7.  VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Authors:  Lisha Wang; Yuping Zhang; Ying-Bei Chen; Stephanie L Skala; Hikmat A Al-Ahmadie; Xiaoming Wang; Xuhong Cao; Brendan A Veeneman; Jin Chen; Marcin Cieślik; Yuanyuan Qiao; Fengyun Su; Pankaj Vats; Javed Siddiqui; Hong Xiao; Evita T Sadimin; Jonathan I Epstein; Ming Zhou; Ankur R Sangoi; Kiril Trpkov; Adeboye O Osunkoya; Giovanna A Giannico; Jesse K McKenney; Pedram Argani; Satish K Tickoo; Victor E Reuter; Arul M Chinnaiyan; Saravana M Dhanasekaran; Rohit Mehra
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

8.  Effect of collecting duct histology on renal cell cancer outcome.

Authors:  Jonathan L Wright; Michael C Risk; James Hotaling; Daniel W Lin
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

Review 9.  Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.

Authors:  Ming Zhao; Xiaodong Teng; Guoqing Ru; Zhongsheng Zhao; Qinqin Hu; Likai Han; Xianglei He
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study.

Authors:  Borislav A Alexiev; Cinthia B Drachenberg
Journal:  Virchows Arch       Date:  2013-03-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.